<DOC>
	<DOCNO>NCT01247883</DOCNO>
	<brief_summary>This study investigate safety , tolerability pharmacokinetics PF-04634817 respectively give orally single tablet dose single dose solution .</brief_summary>
	<brief_title>A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Healthy male and/or female subject ( Healthy define clinically relevant abnormality identify detailed medical history full physical examination . ) Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ; Treatment investigational drug within 30 day 5 halflives ( whichever longer ) precede first dose study medication ; Use tobacco nicotinecontaining product excess equivalent 5 cigarette per day ; Nursing female ; Females childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>relative bioavailability</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>solution</keyword>
	<keyword>tablet</keyword>
</DOC>